Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer (Q33400716)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer |
scientific article |
Statements
1 reference
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer (English)
1 reference
D Ross Camidge
1 reference
Malcolm R Ranson
1 reference
Christine L Hann
1 reference
Edward B Garon
1 reference
Moacyr Ribeiro de Oliveira
1 reference
Philip D Bonomi
1 reference
Quincy Chu
1 reference
Divis Khaira
1 reference
Suresh S Ramalingam
1 reference
Evelyn M McKeegan
1 reference
Brenda J Chyla
1 reference
Barry L Dowell
1 reference
Arunava Chakravartty
1 reference
Cathy E Nolan
1 reference
Niki Rudersdorf
1 reference
Todd A Busman
1 reference
Mack H Mabry
1 reference
Andrew P Krivoshik
1 reference
Rod A Humerickhouse
1 reference
Geoffrey I Shapiro
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference